Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension
Clinical trial NCT00477269 · COMPLETED
Trial details
- NCT number
- NCT00477269
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2014-01-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.